949 related articles for article (PubMed ID: 24857696)
1. Volumetric-modulated arc radiotherapy for pancreatic malignancies: dosimetric comparison with sliding-window intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
Nabavizadeh N; Simeonova AO; Waller JG; Romer JL; Monaco DL; Elliott DA; Tanyi JA; Fuss M; Thomas CR; Holland JM
Med Dosim; 2014; 39(3):256-60. PubMed ID: 24857696
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for pancreatic malignancies.
Ali AN; Dhabaan AH; Jarrio CS; Siddiqi AK; Landry JC
Med Dosim; 2012; 37(3):271-5. PubMed ID: 22189026
[TBL] [Abstract][Full Text] [Related]
3. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
[TBL] [Abstract][Full Text] [Related]
4. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy.
Lin CY; Huang WY; Jen YM; Chen CM; Su YF; Chao HL; Lin CS
Dis Esophagus; 2014 Aug; 27(6):585-90. PubMed ID: 24134466
[TBL] [Abstract][Full Text] [Related]
7. Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT).
Wang X; Li G; Zhang Y; Bai S; Xu F; Wei Y; Gong Y
Med Dosim; 2013; 38(4):395-400. PubMed ID: 23791504
[TBL] [Abstract][Full Text] [Related]
8. Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy.
Haertl PM; Pohl F; Weidner K; Groeger C; Koelbl O; Dobler B
Med Dosim; 2013; 38(1):1-4. PubMed ID: 22727550
[TBL] [Abstract][Full Text] [Related]
9.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Flattening Filter Free on Three-dimensional Conformal Radiation Therapy (3D-CRT), Intensity-Modulated Radiation Therapy (IMRT), and Volumetric Modulated Arc Therapy (VMAT) Plans for Metastatic Brain Tumors from Non-small Cell Lung Cancer.
Shi LW; Lai YQ; Lin Q; Ha HM; Fu LR
Health Phys; 2015 Jul; 109(1):1-9. PubMed ID: 26011493
[TBL] [Abstract][Full Text] [Related]
11. Single Arc Volumetric Modulated Arc Therapy of head and neck cancer.
Bertelsen A; Hansen CR; Johansen J; Brink C
Radiother Oncol; 2010 May; 95(2):142-8. PubMed ID: 20188427
[TBL] [Abstract][Full Text] [Related]
12. Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer.
Cilla S; Caravatta L; Picardi V; Sabatino D; Macchia G; Digesù C; Deodato F; Massaccesi M; De Spirito M; Piermattei A; Morganti AG
Clin Oncol (R Coll Radiol); 2012 May; 24(4):261-8. PubMed ID: 21820294
[TBL] [Abstract][Full Text] [Related]
13. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
[TBL] [Abstract][Full Text] [Related]
14. Comparison of whole-field simultaneous integrated boost VMAT and IMRT in the treatment of nasopharyngeal cancer.
Jin X; Yi J; Zhou Y; Yan H; Han C; Xie C
Med Dosim; 2013; 38(4):418-23. PubMed ID: 23973017
[TBL] [Abstract][Full Text] [Related]
15. Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: a planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique.
Nguyen BT; Hornby C; Kron T; Cramb J; Rolfo A; Pham D; Haworth A; Tai KH; Foroudi F
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):211-9. PubMed ID: 22498196
[TBL] [Abstract][Full Text] [Related]
16. Volumetric-modulated arc therapy versus intensity-modulated radiotherapy for large volume retroperitoneal sarcomas: A comparative analysis of dosimetric and treatment delivery parameters.
Taggar AS; Graham D; Kurien E; Gräfe JL
J Appl Clin Med Phys; 2018 Jan; 19(1):276-281. PubMed ID: 29178585
[TBL] [Abstract][Full Text] [Related]
17. Volumetric-modulated arc radiotherapy for skull-base and non-skull-base head and neck cancer: a treatment planning comparison with fixed Beam IMRT.
Chen J; Mok E; Wang L; Chen C; Le QT
Technol Cancer Res Treat; 2013 Feb; 12(1):11-8. PubMed ID: 22905805
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer planning: Complex conformal vs modulated therapies.
Chapman KL; Witek ME; Chen H; Showalter TN; Bar-Ad V; Harrison AS
Med Dosim; 2016; 41(2):100-4. PubMed ID: 26831922
[TBL] [Abstract][Full Text] [Related]
19. A comparison of volumetric modulated arc therapy and sliding-window intensity-modulated radiotherapy in the treatment of Stage I-II nasal natural killer/T-cell lymphoma.
Liu X; Yang Y; Jin F; He Y; Zhong M; Luo H; Qiu D; Li C; Yang H; He G; Wang Y
Med Dosim; 2016; 41(1):42-6. PubMed ID: 26428072
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy: volumetric modulated arc therapy versus 3D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer.
Herbert C; Kwa W; Nakano S; James K; Moiseenko V; Wu J; Schellenberg D; Liu M
Technol Cancer Res Treat; 2013 Dec; 12(6):511-6. PubMed ID: 23617285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
